This activity is designed to help participants understand and implement the APA Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder. The case study vignette addresses the appropriate use of pharmacotherapy in patients with alcohol use disorder, describes clinical circumstances when it is indicated, discusses potential risks of its use, and lists conditions/clinical features that are contraindications.
- General Member - $15.00
- Resident-Fellow Member - $7.50
- Medical Student Member - $15.00
- Non-Member - $30.00
- Explain the recommendations in the Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (AUD)
- Describe clinical circumstances in which the use of pharmacotherapy is indicated in an individual with AUD
- Identify the potential risks related to the use of pharmacotherapy in individuals with AUD
- List conditions or clinical features that would be a contraindication to use of naltrexone, acamprosate, and disulfiram
Estimated Time to Complete
Estimated Duration: 1 Hour
Program Release: January 4, 2018
Program End: January 4, 2021
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple-choice quiz is provided based on the content. A passing score of 50% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
- Jeremy D. Kidd, MD, MPH, NIDA T32 Research Fellow in Substance Use Disorders, Department of Psychiatry, Division on Substance Use Disorders. Columbia University/New York State Psychiatric Institute; Consultant Member, Guideline Writing Group, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Laura J. Fochtmann, MD, MBI, Distinguished Service Professor, Departments of Psychiatry, Pharmacological Sciences and Biomedical Informatics, StonyBrook University School of Medicine; Medical Editor, Practice Guidelines, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Victor Reus, MD, Distinguished Professor, Department of Psychiatry and Langley Porter Institute, Weill Institute for Neurosciences, University of California San Francisco School of Medicine; Chair, Guideline Writing Group, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Jennifer Medicus, Deputy Director, Practice Guidelines, American Psychiatric Association. Reports no financial relationships with commercial interests.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org for questions about this course | Contact email@example.com for technical assistance
All materials copyright American Psychiatric Association ©2018.